Editorial Board Member - JATES
Dr. Xiaoqing Guo received her Master’s degree in Pathology and a Ph.D. degree in Medical Sciences from Hebei Medical University, China in 1999 and 2005, respectively. She started her scientific career in 1999 in clinical cancer research, including diagnosis and treatment of early cancers, as a physician in the 4th Affiliated Hospital of Hebei Medical University, also known as the Hebei Cancer Institute. Her Ph.D. training extended her career into molecular biomarker screening for esophageal cancer in a high-risk area of China. In June of 2008, Dr. Guo was recruited as a postdoctoral fellow in the Division of Genetic and Molecular Toxicology (DGMT) at the National Center for Toxicological Research (NCTR). Following the postdoctoral training, Dr. Guo was hired as a Research Associate in Toxicologic Pathology Associates, Inc. (TPA) and in January of 2012, Dr. Guo joined the NCTR/DGMT as an FDA Staff Fellow. Dr. Guo has authored or coauthored more than 50 papers. Currently, she serves on the editorial and scientific review boards of several toxicological journals. She holds memberships with the Society of Toxicology, Environmental Mutagenesis and Genomics Society.
Dr. Xiaoqing Guo’s current research interest is to develop pathway-based, medium- or high-throughput, and high-content (HTHC) approaches for genotoxicity testing. She also is interested in mechanistic study for chemical-induced genotoxicity.
Other Editorial Board Members - JATES
Ruđer Bošković Institute
Center for marine Research Rovinj
Pesticide Chemistry Department
National Research Centre (NRC)
Rimkus Consulting Group
Faculty of Science
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences
University of Messina